Hexahydrocurcumin from Zingiberis rhizoma attenuates lipopolysaccharide-induced acute pneumonia through JAK1/STAT3 signaling pathway-Reference-Cited by-同舟云学术

Hexahydrocurcumin from Zingiberis rhizoma attenuates lipopolysaccharide-induced acute pneumonia through JAK1/STAT3 signaling pathway

Published:2024-01 Issue: Volume:122 Page:155141
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Li Ruopeng^ORCID,Liang Qinghe,Yang Qin,Dai Wenqi,Xiao Yao,Pan Hudan,Zhang Zhongde,Liu Liang,Li Xiaojuan^ORCID

Funder

Key Technologies Research and Development Program

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference53 articles.

1. The dynamic interplay between AMPK/NFκB signaling and NLRP3 is a new therapeutic target in inflammation: Emerging role of dapagliflozin in overcoming lipopolysaccharide-mediated lung injury;Abd El-Fattah;Biomed. Pharmacother.,2022

2. NF-kappaB activation;Abraham;Crit. Care Med.,2000

3. Dexamethasone Attenuates LPS-induced Acute Lung Injury through Inhibition of NF-kappaB, COX-2, and Pro-inflammatory Mediators;Al-Harbi;Immunol. Invest.,2016

4. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects;Banerjee;Drugs,2017

5. Understanding the roles of cytokines and neutrophil activity and neutrophil apoptosis in the protective versus deleterious inflammatory response in pneumonia. International journal of infectious diseases;Bordon;IJID,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor;Phytomedicine;2024-07

2. Lianweng Granules Alleviate Intestinal Barrier Damage via the IL-6/STAT3/PI3K/AKT Signaling Pathway with Dampness-Heat Syndrome Diarrhea;Antioxidants;2024-05-28

3. Hexahydrocurcumin attenuated demyelination and improved cognitive impairment in chronic cerebral hypoperfusion rats;Inflammopharmacology;2023-12-28